搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medscape
3 天
Tramadol in the Treatment of Neuropathic Cancer Pain
Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics ...
14 天
New Pain Pathway Discovery Could Revolutionize Chronic Pain Treatment
Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...
Pharmaceutical Technology
6 天
BHV-2100 by Biohaven for Neuropathic Pain (Neuralgia): Likelihood of Approval
BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia).
UUHC Health Feed
4 天
Pain Relief Through Physical Therapy
Physical therapy can be effective in treating a condition more than 3 million Americans live with every day: chronic pain.
Knowridge
3 天
A breakthrough non-surgical treatment for knee pain
For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.
Business Wire
5 天
A Novel Non-Opioid Multimodal Analgesic from Xgene Pharmaceutical Reduces Pain and a Need ...
Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...
Pharmaceutical Technology
7 天
ANP-390 by AlphaNavi Pharma for Peripheral Neuropathic Pain: Likelihood of Approval
ANP-390 is under clinical development by AlphaNavi Pharma and currently in Phase I for Peripheral Neuropathic Pain.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈